
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
MRG1 CRISPR/Cas9 KO Plasmid (m) | sc-421714 | 20 µg | $397.00 |
Cited2 encodes the transcriptional co-regulator MRG1, a nuclear protein that binds CBP/p300 and modulates gene expression programs controlling proliferation, differentiation, and cellular stress responses in mouse cells. By integrating signals from hypoxia-responsive and developmental transcription factors, MRG1 influences HIF-dependent transcriptional outputs and broader chromatin-mediated regulation of lineage specification. Cited2 activity is linked to embryogenesis and organogenesis, and altered regulation of this pathway has been associated with defects in cardiovascular and hematopoietic development. As a context-dependent regulator of transcriptional networks, Cited2 is frequently studied in models of inflammation, metabolic stress, and tumor biology where co-activator availability and hypoxic signaling shape cell fate decisions.
MRG1 CRISPR/Cas9 KO Plasmid (m) is a pool of plasmids designed for targeted disruption of the Cited2 gene in mouse cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the Cited2 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the Cited2 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish MRG1 protein expression.
This CRISPR knockout system enables efficient generation of Cited2-deficient cell models for investigation of MRG1 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.